Centrophenoxine

Centrophenoxine

Identifiers
IUPAC name 2-dimethylaminoethyl 2-(4-chlorophenoxy)acetate
CAS Number	51-68-3
PubChem CID	4039
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C12H16ClNO3
Molar mass	257.713

WikiDoc Resources for Centrophenoxine
Articles
Most recent articles on Centrophenoxine Most cited articles on Centrophenoxine Review articles on Centrophenoxine Articles on Centrophenoxine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Centrophenoxine Images of Centrophenoxine Photos of Centrophenoxine Podcasts & MP3s on Centrophenoxine Videos on Centrophenoxine
Evidence Based Medicine
Cochrane Collaboration on Centrophenoxine Bandolier on Centrophenoxine TRIP on Centrophenoxine
Clinical Trials
Ongoing Trials on Centrophenoxine at Clinical Trials.gov Trial results on Centrophenoxine Clinical Trials on Centrophenoxine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Centrophenoxine NICE Guidance on Centrophenoxine NHS PRODIGY Guidance FDA on Centrophenoxine CDC on Centrophenoxine
Books
Books on Centrophenoxine
News
Centrophenoxine in the news Be alerted to news on Centrophenoxine News trends on Centrophenoxine
Commentary
Blogs on Centrophenoxine
Definitions
Definitions of Centrophenoxine
Patient Resources / Community
Patient resources on Centrophenoxine Discussion groups on Centrophenoxine Patient Handouts on Centrophenoxine Directions to Hospitals Treating Centrophenoxine Risk calculators and risk factors for Centrophenoxine
Healthcare Provider Resources
Symptoms of Centrophenoxine Causes & Risk Factors for Centrophenoxine Diagnostic studies for Centrophenoxine Treatment of Centrophenoxine
Continuing Medical Education (CME)
CME Programs on Centrophenoxine
International
Centrophenoxine en Espanol Centrophenoxine en Francais
Business
Centrophenoxine in the Marketplace Patents on Centrophenoxine
Experimental / Informatics
List of terms related to Centrophenoxine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Centrophenoxine (also called Meclofenoxate, and formerly sold under the brand name Lucidril®) is a drug used to treat the symptoms of senile dementia and Alzheimer's Disease. It is a compound of two biochemicals: dimethylaminoethanol (DMAE) and parachlorophenoxyacetate (pCPA). DMAE is a natural substance, found especially in fish, and also produced in the human brain. pCPA is a synthetic compound that resembles to a variety of plant hormones called auxins.

Like DMAE, it is a precursor to the neurotransmitter acetylcholine and may increase levels of this chemical in the CNS. It is reported to improve memory and general cognition.

It is also used off-label as a nootropic, often combined with a racetam drug such as piracetam.

Side Effects & Contraindications

Possible side effects may include nausea or mild dizziness. People with severely high blood pressure or convulsive disorders such as epilepsy should avoid Centrophenoxine. ^[1] Large doses may cause tight jaw clenching.

References

1. Centrophenoxine Page @ The American Academy of Anti-Aging Medicine

External links

• Collection of Scientific Abstracts on Centrophenoxine

Template:Treatment-stub Template:Psychostimulants, agents used for ADHD and nootropics de:Centrophenoxin